Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1263 clinical trials
Featured trial
A Phase 3, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy, Safety, And Tolerability Of Atogepant For The Prevention Of Chronic Migraine (PROGRESS)

. Treatment groups include 30mg twice daily, 60mg once daily, and placebo. This study will consist of a 4-week screening and baseline period, a 12-week double-blind treatment period

  • 358 views
  • 03 Aug, 2020
  • 1 location
Featured trial
Depression

the US population meets criteria for major depressive disorder over a 12-month period and women are 1.5-3 times as likely as men to develop MDD. Some treatments which have been

suicidal
depressive symptoms
transcranial magnetic stimulation
behavior therapy
depressive disorder
  • 137 views
  • 30 Jul, 2021
  • 1 location
Featured trial
Birth Control Pill Study- Clinical Research Study of an investigational oral medication for Birth Control .

Birth Control Pill Study- Clinical Research Study of an investigational oral medication for Birth Control .

  • 1372 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Phase 2, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dose Levels of XP23829 in Subjects with Moderate-to-Severe Chronic Plaque-Type Psoriasis

A Phase 2, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dose Levels of XP23829 in Subjects with Moderate-to-Severe Chronic Plaque-Type Psoriasis

  • 278 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A double-blind, randomized, parallel-group vehicle-controlled, multi-center study comparing a generic tazarotene cream, 0.05% to reference listed drug tazorac (tazarotene) cream, 0.05% and both active treatments to a vehicle control in the treatment of plaque psoriasis

A double-blind, randomized, parallel-group vehicle-controlled, multi-center study comparing a generic tazarotene cream, 0.05% to reference listed drug tazorac (tazarotene) cream, 0.05% and both active treatments to a vehicle control in the treatment of plaque psoriasis

  • 186 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Longitudinal Gait and Balance Measurement

Longitudinal Gait and Balance Measurement

  • 268 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of XXXXXX in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of XXXXXX in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

  • 644 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

  • 271 views
  • 23 Nov, 2020
  • 1 location
Featured trial
An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

  • 394 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A Randomized, double-blind, parallel-group, 12-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010 compared to PT009 in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD).

A Randomized, double-blind, parallel-group, 12-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010 compared to PT009 in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD).

  • 548 views
  • 25 Mar, 2021
  • 1 location